# CSB Bancorp, Inc.: overview CSBB · OTC · CIK 880417 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/csbb.md) · [Financials](/companies/csbb/financials.md) · [Filings](/companies/csbb/filings.md) · [Insiders](/companies/csbb/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.18](/filings/0001193125-25-277449.md) | not reported | [1.37](/filings/0000880417-26-000004.md) | [1.41](/filings/0001193125-26-348468.md) | [1.57](/filings/0001193125-25-277449.md) | not reported | [1.69](/filings/0000880417-26-000004.md) | [1.80](/filings/0001193125-26-348468.md) | | Free cash flow | $k | [2,246 d](/filings/0001193125-25-277449.md) | [6,499 d](/filings/0001193125-26-108381.md) | [2,959](/filings/0000880417-26-000004.md) | [4,354 d](/filings/0001193125-26-348468.md) | [5,640 d](/filings/0001193125-25-277449.md) | [6,131 d](/filings/0001193125-26-108381.md) | [3,059](/filings/0000880417-26-000004.md) | [6,178 d](/filings/0001193125-26-348468.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.97](/filings/0000950170-23-008442.md) | [4.91](/filings/0000950170-24-032295.md) | [5.51](/filings/0000950170-25-039227.md) | [3.76](/filings/0001193125-26-108381.md) | [5.07](/filings/0001193125-26-108381.md) | | Free cash flow | $m | [13.0](/filings/0000950170-23-008442.md) | [14.0](/filings/0000950170-24-032295.md) | [15.2](/filings/0000950170-25-039227.md) | [13.7](/filings/0001193125-26-108381.md) | [19.1](/filings/0001193125-26-108381.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/csbb/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $4.2m | 58,284 | | Reduced −8,279 | ## Recent filings [All 613 filings](/companies/csbb/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-20 | 20:08 ET | [8-K](/filings/0001193125-26-426681.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-426681 | | 2026-08-26 | 20:04 ET | [8-K](/filings/0001193125-26-368277.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-368277 | | 2026-08-13 | 16:15 ET | [10-Q](/filings/0001193125-26-348468.md) | Quarterly report, period 2026-06-30 | 0001193125-26-348468 | | 2026-07-21 | 20:05 ET | [8-K](/filings/0001193125-26-310284.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-310284 | | 2026-05-14 | 19:28 ET | [10-Q](/filings/0000880417-26-000004.md) | Quarterly report, period 2026-03-31 | 0000880417-26-000004 | | 2026-04-23 | 19:36 ET | [8-K](/filings/0001193125-26-173545.md) | 5.07 Shareholder vote results | 0001193125-26-173545 | | 2026-04-20 | 20:04 ET | [8-K](/filings/0001193125-26-163929.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-163929 | | 2026-03-16 | 21:06 ET | [DEF 14A](/filings/0001193125-26-108585.md) | Proxy statement, period 2026-03-16 | 0001193125-26-108585 | | 2026-03-16 | 20:19 ET | [10-K](/filings/0001193125-26-108381.md) | Annual report, period 2025-12-31 | 0001193125-26-108381 | | 2026-02-25 | 21:03 ET | [8-K](/filings/0001193125-26-071483.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-071483 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-108381.md), filed Mar 16, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 880417 - Tickers: CSBB - Exchange: OTC - SIC code: 6022 State Commercial Banks - State of incorporation: OH - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:26 ET. No prices; not investment advice.